These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34467534)

  • 1. Cardiac-specific deletion of FDPS induces cardiac remodeling and dysfunction by enhancing the activity of small GTP-binding proteins.
    Wang X; Zhang X; Chen Y; Zhao C; Zhou W; Chen W; Zhang C; Ding K; Li W; Xu H; Lou L; Chu Z; Hu S; Yang J
    J Pathol; 2021 Dec; 255(4):438-450. PubMed ID: 34467534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac decompensation and promiscuous prenylation of small GTPases in cardiomyocytes in response to local mevalonate pathway disruption.
    Essandoh K; Auchus RJ; Brody MJ
    J Pathol; 2022 Mar; 256(3):249-252. PubMed ID: 34783037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling.
    Zhao CZ; Zhao XM; Yang J; Mou Y; Chen B; Wu HD; Dai DP; Ding J; Hu SJ
    Sci Rep; 2016 Dec; 6():39186. PubMed ID: 28008986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
    Yang Y; Rong X; Lv X; Jiang W; Yang Y; Lai D; Xu S; Fu G
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.
    Chen B; Zhong LY; Yang JX; Pan YY; Chen F; Yang J; Wu T; Hu SJ
    Cell Physiol Biochem; 2013; 32(6):1761-75. PubMed ID: 24356578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of enzyme expressions in mevalonate pathway: possible role for cardiovascular remodeling in spontaneously hypertensive rats.
    Han J; Jiang DM; Du CQ; Hu SJ
    Circ J; 2011; 75(6):1409-17. PubMed ID: 21467659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzyme-coupled continuous fluorescence assay for farnesyl diphosphate synthases.
    Dozier JK; Distefano MD
    Anal Biochem; 2012 Feb; 421(1):158-63. PubMed ID: 22085443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.
    Yang J; Chen YN; Xu ZX; Mou Y; Zheng LR
    Cell Physiol Biochem; 2016; 39(1):229-41. PubMed ID: 27336844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.
    Abate M; Laezza C; Pisanti S; Torelli G; Seneca V; Catapano G; Montella F; Ranieri R; Notarnicola M; Gazzerro P; Bifulco M; Ciaglia E
    Sci Rep; 2017 Oct; 7(1):14123. PubMed ID: 29075041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis.
    Liu J; Zhang X; Zhang Y; Qian M; Yang M; Yang S; Wang L
    FASEB J; 2023 Jul; 37(7):e23035. PubMed ID: 37310396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.
    Zhang C; Jin DD; Wang XY; Lou L; Yang J
    J Cardiovasc Pharmacol; 2021 Feb; 77(2):142-152. PubMed ID: 33538531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
    Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and functional analysis of cis-acting elements of the human farnesyl diphosphate synthetase (FDPS) gene 5' flanking region.
    Romanelli MG; Lorenzi P; Sangalli A; Diani E; Mottes M
    Genomics; 2009 Mar; 93(3):227-34. PubMed ID: 19056481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation.
    Jiang X; Pan H; Nabhan JF; Krishnan R; Koziol-White C; Panettieri RA; Lu Q
    FASEB J; 2012 May; 26(5):1995-2007. PubMed ID: 22278941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.
    Nuttall JM; Hettema EH; Watts DJ
    Biochem J; 2012 Nov; 447(3):353-61. PubMed ID: 22849378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.
    Kim HY; Kim DK; Bae SH; Gwak H; Jeon JH; Kim JK; Lee BI; You HJ; Shin DH; Kim YH; Kim SY; Han SS; Shim JK; Lee JH; Kang SG; Jang H
    Exp Mol Med; 2018 Oct; 50(10):1-12. PubMed ID: 30333528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells.
    Ishimoto K; Tachibana K; Hanano I; Yamasaki D; Nakamura H; Kawai M; Urano Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T
    Biochem J; 2010 Jul; 429(2):347-57. PubMed ID: 20450493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.